Teva announced the launch of Amlodipine, Valsartan, and Hydrochlorothiazide Tablets, the generic version of Novartis ‘ Exforge HCT. Exforge HCT contains amlodipine, a calcium channel blocker ...

The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...